Related Experiment Video

Updated: May 20, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Potential role for STAT3 inhibitors in glioblastoma

Christopher Jackson1, Jacob Ruzevick, Anubhav G Amin

  • 1Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Neurosurgery Clinics of North America
|July 4, 2012
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) plays a complex role in glioblastoma multiforme, a common brain cancer. This review explores STAT3

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Glioblastoma multiforme (GBM) is an aggressive primary brain tumor.
  • Signal transducer and activator of transcription 3 (STAT3) is a key transcription factor involved in cancer cell survival and proliferation.
  • Constitutive STAT3 activation is observed in several cancers, often targeted for therapeutic benefit.

Purpose of the Study:

  • To review the multifaceted roles of STAT3 in GBM pathogenesis.
  • To discuss the emerging evidence suggesting a nuanced role for STAT3 in GBM.
  • To explore potential therapeutic strategies targeting STAT3 in GBM.

Main Methods:

  • Literature review of studies on STAT3 signaling in GBM.
  • Analysis of gene expression and protein activity data related to STAT3.
  • Discussion of preclinical and clinical data on STAT3 inhibitors in GBM.

Main Results:

  • STAT3 activation is frequently observed in GBM.
  • While STAT3 inhibition shows antineoplastic effects, its precise role in GBM is complex and context-dependent.
  • Emerging evidence suggests STAT3 may have both pro- and anti-tumorigenic functions in GBM.

Conclusions:

  • The role of STAT3 in GBM is more complex than previously thought.
  • Targeting STAT3 in GBM requires a nuanced approach, considering its dual functions.
  • Further research is needed to fully elucidate STAT3's role and optimize therapeutic strategies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...